1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Functional Technologies's 1-Year ROIIC % for the quarter that ended in Aug. 2012 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Functional Technologies's 1-Year ROIIC % or its related term are showing as below:
TSXV:FEB.H's 1-Year ROIIC % is not ranked *
in the Biotechnology industry.
Industry Median: -4.24 * Ranked among companies with meaningful 1-Year ROIIC % only.
Functional Technologies 1-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Functional Technologies's 1-Year ROIIC %
For the Biotechnology subindustry, Functional Technologies's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Functional Technologies's 1-Year ROIIC % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Functional Technologies's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Functional Technologies's 1-Year ROIIC % falls into.
Functional Technologies's 1-Year ROIIC % for the quarter that ended in Aug. 2012 is calculated as:
1-Year ROIIC %
=
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( -4.668 (Aug. 2012) - -4.9411476 (Aug. 2011) )
/
( 6.661 (Aug. 2012) - 6.368 (Aug. 2011) )
=
0.2731476
/
0.293
=
93.22%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Functional Technologies 1-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Functional Technologies's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Functional Technologies (TSXV:FEB.H) Business Description
Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:FEB.H has been successfully added to your 